U.S. Pharmaceutical Corporation Uses NAFTA Foreign Investor Privileges Regime to Attack Canada’s Patent Policy, Demand $100 Million for Invalidation of a Patent March 1, 2017
Quote Sheet: Selected Government Statements and Actions Against Investor-State Dispute Settlement October 19, 2016
Polling Memo: Public Anger About Corporate Power Dominant Factor in Views on Trade and TPP. July 13, 2016
TransCanada Corporation & TransCanada PipeLines Limited v. The Government of the United States of America (Keystone XL crude oil pipeline)